Risperidone in the treatment of mania

Journal of Clinical Psychiatry

Volumn 57, Issue 6, 1996, Pages 249-253

  Tohen, Mauricio ^a,b,c   Zarate Jr , Carlos A ^a,b   Centorrino, Franca ^a,b   Hegarty, James I ^a,b   Froeschl, Michael ^a   Zarate, Silvina B ^a  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM CARBONATE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MANIA; MOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CONFIDENCE INTERVALS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; MALE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0029901694     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Livingston MG. Risperidone. Lancet 1994;343:457-460
2. Borison RL, Rathiraja AP, Bruce I, el al. Risperidone clinical safety and efficacy in schizophrenia. Psychopharmacol Bull 1992;28:213-218
3. Claus A, Bollen J, De Cuyper H, et al. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multi-centre, double-blind comparative study. Acta Psychiatr Scand 1992;85:295-305
4. Heinrich K, Klieser E, Lehmann E, et al. Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:129-137
5. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
6. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300
7. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-417
8. Zarate CA Jr, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
9. Patel JK, Green AI, Banov MD, et al. Clozapine use in treatment refractory mania and psychosis. In: New Research Program and Abstracts of the 148th annual meeting of the American Psychiatric Association; May 24, 1995; Miami, Fla. Abstract NR478:183
10. Frankenburg FR, Zanarini MC. Uses of clozapine in nonschizophrenic patients. Harvard Review of Psychiatry 1994;2:142-150
11. Dwight MM, Keck PE Jr, Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994;344:554-555
12. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry 1992;25:213-217
13. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995;56:423-429
14. Goodnick PJ. Risperidone treatment of refractory acute mania [letter]. J Clin Psychiatry 1995;56:431-432
15. Singh AN, Catalan J. Risperidone in HIV-related manic psychosis. Lancet 1994;344:1029-1030
16. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometric Research, New York State Psychiatric Institute; 1987
17. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
18. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;113:429-435
19. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676
20. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212:11-19
21. Ceskova AB. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Pharmacopsychiatry 1993; 26:121-124
22. Sajatovic M. A pilot study evaluating the efficacy of risperidone in treatment refractory acute bipolar and schizoaffective mania. In: Abstracts, Posters and Presentations of the 35th annual meeting of the New Clinical Drug Evaluation Unit Program; May 31-June 3, 1995; Orlando, Fla. Poster no. 19
23. Suppes T, Phillips KA, Judd CR. Clozapine treatment of nonpsychotic rapid cycting bipolar disorder: a report of three cases. Biol Psychiatry 1994;36:338-340
24. Keck PE Jr, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. In: New Research Program and Abstracts of the 148th annual meeting of the American Psychiatric Association; May 24, 1995; Miami, Fla. Abstract NR484:185
25. Ghaemi SN, Sachs GS, Baldassano CF, et al. Management of bipolar disorder with adjunctive risperidone: response to open treatment. In: New Research Program and Abstracts of the 148th annual meeting of the American Psychiatric Association; May 22, 1995; Miami, Fla. Abstract NR82:77
26. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135
27. Tohen M. Course and treatment outcome in patients with mania. In: Mirin SM, Gossett JT, Grob MC, eds. Psychiatric Treatment: Advances in Outcome Research. Washington, DC: American Psychiatric Press; 1991: 127-142
28. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex sodium vs lithium and placebo in the treatment of mania. JAMA 1994; 271:918-924
29. Pope HG Jr, McElroy SL, Keck PE Jr, et al. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48: 62-68